Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation

Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest - Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc litigation over ovarian cancer claims.